Pfizer has given up on its attempt to take over the British pharmaceutical company AstraZeneca.
The American drug maker announced Monday that it was withdrawing its latest in a series of unsolicited offers.
That bid valued AstraZeneca (AZN) at nearly $120 billion, a 45% premium over the company’s share price in mid-April. If the deal had been accepted, it would have been one of the biggest drug takeovers in history.
Help employers find you! Check out all the jobs and post your resume.
